How a GP initiated engagement model could be the way forward for the pharmaceutical industry

A survey of almost 400 GPs conducted by ADG on their contact with pharmaceutical field staff early in the pandemic, found a significant drop in face-to-face engagement. This paper shows that through the adoption of new technologies and by accepting greater GP input into when and how engagements take place, pharmaceutical company support and education will remain as relevant and important as ever to GPs.

The future of the pharmaceutical and GP engagement model (2020)

A series of surveys and research conducted by ADG are published for the first time. In this white paper, you'll find; longitudinal trend data for GP access by sales reps, qualitative insights into the digital doctor, global and local solutions to this changing environment and how to prioritise information for GPs from the perspective of GPs.

Inside Healthcare is our newsletter and blog featuring thought-leading articles, news stories and resources on the hottest topics within the pharmaceutical and healthcare marketing industry.

Make sure you are subscribed to the newsletter to stay on the pulse.